By Karen Pallarito NEW YORK (Reuters Health) Sept 25 –
Academic institutions must establish policies for assuring that their financial interests do not compromise the well-being of human subjects in the clinical trials they conduct, an expert panel said this week.
Weak conflict of interest policies may pose a risk to the safety and welfare of human subjects and threaten public faith in the research enterprise, according to the latest report from the Association of American Medical Colleges’ (AAMC’s) task force on financial conflicts of interest.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!